CASP3 and cancer: Furthermore, the activation of early apoptotic events, as well as caspase 3/7 enzymes, suggests that the dual therapeutic activity of the drug-loaded nanopolymers is irreversible and cytotoxic to rapidly proliferating cancer cells.